Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study.
about
High pneumococcal DNA load, procalcitonin and suPAR levels correlate to severe disease development in patients with pneumococcal pneumonia.suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients.The intriguing role of soluble urokinase receptor in inflammatory diseases.Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD.Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Predictor of Incident Atrial Fibrillation.Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III)
P2860
Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Soluble urokinase plasminogen ...... A retrospective cohort study.
@en
Soluble urokinase plasminogen ...... A retrospective cohort study.
@nl
type
label
Soluble urokinase plasminogen ...... A retrospective cohort study.
@en
Soluble urokinase plasminogen ...... A retrospective cohort study.
@nl
prefLabel
Soluble urokinase plasminogen ...... A retrospective cohort study.
@en
Soluble urokinase plasminogen ...... A retrospective cohort study.
@nl
P2093
P2860
P50
P1476
Soluble urokinase plasminogen ...... A retrospective cohort study.
@en
P2093
Gertrude Ellekilde
Jørgen Hjelm Poulsen
Steen Ladelund
Thomas Huneck Haupt
P2860
P304
P356
10.1136/EMERMED-2015-205444
P407
P577
2016-09-02T00:00:00Z